We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Dave & Buster's
PLAY
$358M
| $623K | ﹤0.01% |
20,080
-8,720
| -30% | -$326K |
|
1352
E.W. Scripps
SSP
$270M
| $622K | ﹤0.01% |
55,234
| – | – |
|
1353
Enovis
ENOV
$1.71B
| $620K | ﹤0.01% |
13,456
| – | – |
|
1354
Hilltop Holdings
HTH
$2.27B
| $620K | ﹤0.01% |
24,940
| – | – |
|
|
BBT
1355
Beacon Financial Corp
BBT
$2.51B
| $617K | ﹤0.01% |
22,590
| – | – |
|
1356
Trupanion
TRUP
$1.12B
| $616K | ﹤0.01% |
10,370
-1,990
| -16% | -$134K |
|
1357
Lakeland Financial Corp
LKFN
$1.58B
| $612K | ﹤0.01% |
8,400
| – | – |
|
|
PRA
1358
DELISTED
ProAssurance
PRA
| $612K | ﹤0.01% |
31,380
| – | – |
|
|
YMAB
1359
DELISTED
Y-mAbs Therapeutics
YMAB
| $608K | ﹤0.01% |
42,152
| – | – |
|
1360
JetBlue
JBLU
$2.15B
| $600K | ﹤0.01% |
90,502
-23,690
| -21% | -$193K |
|
1361
Terreno Realty
TRNO
$7.53B
| $600K | ﹤0.01% |
+11,320
| New | +$681K |
|
1362
Digital Turbine
APPS
$997M
| $597K | ﹤0.01% |
41,448
| – | – |
|
1363
Alpha Metallurgical Resources
AMR
$1.75B
| $594K | ﹤0.01% |
4,340
+3,640
| +520% | +$506K |
|
|
UNIT
1364
Uniti Group
UNIT
$2.47B
| $594K | ﹤0.01% |
85,528
| – | – |
|
|
AXNX
1365
DELISTED
Axonics, Inc. Common Stock
AXNX
| $592K | ﹤0.01% |
8,400
+1,950
| +30% | +$135K |
|
|
CNCE
1366
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $592K | ﹤0.01% |
88,341
| – | – |
|
1367
Marqeta
MQ
$1.91B
| $590K | ﹤0.01% |
20,723
+4,325
| +26% | +$144K |
|
|
SAGE
1368
DELISTED
Sage Therapeutics
SAGE
| $590K | ﹤0.01% |
15,060
+7,120
| +90% | +$275K |
|
1369
Neogen
NEOG
$1.98B
| $589K | ﹤0.01% |
42,158
+12,810
| +44% | +$258K |
|
|
RVNC
1370
DELISTED
Revance Therapeutics, Inc.
RVNC
| $589K | ﹤0.01% |
21,800
| – | – |
|
|
FOLD
1371
DELISTED
Amicus Therapeutics
FOLD
| $588K | ﹤0.01% |
56,290
-177,269
| -76% | -$1.98M |
|
1372
Genmab
GMAB
$17.5B
| $585K | ﹤0.01% |
18,200
| – | – |
|
1373
Privia Health
PRVA
$3.08B
| $584K | ﹤0.01% |
17,140
+10,850
| +172% | +$401K |
|
1374
International Bancshares
IBOC
$4.83B
| $583K | ﹤0.01% |
13,707
| – | – |
|
1375
Comstock Resources
CRK
$3.67B
| $582K | ﹤0.01% |
33,640
+20,530
| +157% | +$340K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.